Transgene Biotek

Transgene_Biotek02 May 2024

Healthcare

₹

-0.01 (-0.14%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Transgene Biotek

Transgene Biotek

Healthcare

Transgene_Biotek02 May 2024

₹

-0.01 (-0.14%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-Jan-2024	BC	TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. To consider and approve the Un-Audited	14-Feb-2024
14-Nov-2023	BC	Outcome of Board Meeting 33rd Annual Report 2022-2023. Intimation of Book Closure. (As Per BSE Announcement Dated on 01.12.2023) AGM 30/12/2023 (As Per BSE Bulletin Dated on 01.12.2023	30-Dec-2023
01-Jan-2024	BC	Outcome of voting Results of 33rd AGM and Scrutinizer ''s Report	30-Dec-2023
14-Nov-2023	BC	Outcome of Board Meeting	26-Dec-2023
06-Nov-2023	BC	TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve 1) To consider and approve the Un-Audited	14-Nov-2023

No Rights has been declared by Transgene_Biotek

Book Closure

Record Date	Split Date	Purpose
14-Feb-2024	-	TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. To consider and approve the Un-Audited
30-Dec-2023	-	Outcome of Board Meeting 33rd Annual Report 2022-2023. Intimation of Book Closure. (As Per BSE Announcement Dated on 01.12.2023) AGM 30/12/2023 (As Per BSE Bulletin Dated on 01.12.2023
30-Dec-2023	-	Outcome of voting Results of 33rd AGM and Scrutinizer ''s Report
26-Dec-2023	01 Jan'1900	Outcome of Board Meeting
14-Nov-2023	-	TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve 1) To consider and approve the Un-Audited

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Transgene Biotek Ltd ₹7.07(-0.01/-0.14%)	7.07	-0.01	53.57	162.83	0.00	-8.27
Kovai Medical Center & Hospital Ltd ₹4,060.70(-124.35/-2.97%)	4,060.70	-124.35	4,442.41	105.40	28.10	5.69
Shree Pacetronix Ltd ₹230.85(-12.15/-5.00%)	230.85	-12.15	83.09	89.22	21.24	7.33
Fortis Malar Hospitals Ltd ₹89.19(-1.82/-2.00%)	89.19	-1.82	167.16	79.96	0.00	2.93
Chennai Meenakshi Multispeciality Hospital Ltd ₹35.51(-0.92/-2.53%)	35.51	-0.92	26.53	70.48	98.64	148.77
Apollo Hospitals Enterprise Ltd ₹5,956.00(+9.80/0.16%)	5,956.00	+9.80	85,638.14	32.88	85.76	11.74

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.05	0.05	0.10	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.05	0.05	0.10	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.04	0.04	0.04	0.04	0.04	0.04
Total Income	0.09	0.09	0.14	0.04	0.04	0.04
Total Expenditure	0.15	0.17	0.22	0.23	0.14	0.53
PBIDT	-0.06	-0.08	-0.08	-0.19	-0.10	-0.49
Interest	0.03	0.03	0.03	0.05	0.05	0.05
PBDT	-0.10	-0.11	-0.11	-0.23	-0.14	-0.53
Depreciation	0.02	0.02	0.02	1.24	1.24	1.24
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.12	-0.13	-0.13	-1.47	-1.38	-1.77
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.12	-0.13	-0.13	-1.47	-1.38	-1.77

EPS (Unit Curr.)	-0.02	-0.02	-0.17	-0.19	-0.18	-0.23
EPS (Adj) (Unit Curr.)	-0.02	-0.02	-0.17	-0.19	-0.18	-0.23
Calculated EPS (Unit Curr.)	-0.02	-0.02	-0.02	-0.19	-0.18	-0.23
Calculated EPS (Adj) (Unit Curr.)	-0.02	-0.02	-0.02	-0.19	-0.18	-0.23
Calculated EPS (Ann.) (Unit Curr.)	-0.06	-0.07	-0.07	-0.78	-0.73	-0.93
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-0.06	-0.07	-0.07	-0.78	-0.73	-0.93
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	75.77	75.77	75.77	75.77	75.77	75.77
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-120.00	-160.00	-80.00	0.00	0.00	0.00
PBDTM(%)	-200.00	-220.00	-110.00	0.00	0.00	0.00
PATM(%)	-240.00	-260.00	-130.00	0.00	0.00	0.00

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	0.05	0.05	0.10	0.00	0.00	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	0.05	0.05	0.10	0.00	0.00	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.04	0.04	0.04	0.04	0.04	0.04
Total Income	0.09	0.09	0.14	0.04	0.04	0.04
Total Expenditure	0.15	0.17	0.23	0.23	0.14	0.53
PBIDT	-0.06	-0.08	-0.08	-0.19	-0.10	-0.49
Interest	0.03	0.03	0.03	0.05	0.05	0.05
PBDT	-0.10	-0.11	-0.12	-0.23	-0.14	-0.53
Depreciation	0.02	0.02	0.02	1.24	1.24	1.24
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.12	-0.13	-0.14	-1.47	-1.38	-1.77
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	-0.12	-0.13	-0.14	-1.47	-1.38	-1.77

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.12	-0.13	-0.14	-1.47	-1.38	-1.77

EPS (Unit Curr.)	-0.02	-0.02	-0.02	-0.19	-0.18	-0.23
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	75.77	75.77	75.77	75.77	75.77	75.77

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-120.00	-160.00	-80.00	0.00	0.00	0.00
PBDTM(%)	-200.00	-220.00	-120.00	0.00	0.00	0.00
PATM(%)	-240.00	-260.00	-140.00	0.00	0.00	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	75.77	75.77	75.77	75.77	75.77	75.77
Reserves Total	-81.98	-75.97	-71.11	-60.67	-49.71	-40.92
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	-6.21	-0.20	4.66	15.10	26.06	34.85
Secured Loans	4.80	4.62	4.39	4.13	3.95	3.69
Unsecured Loans	8.32	7.40	6.94	6.20	5.19	6.15
Total Debt	13.12	12.02	11.33	10.33	9.14	9.84
Total Liabilities	6.91	11.82	15.99	25.43	35.20	44.69
APPLICATION OF FUNDS :
Gross Block	107.61	107.61	107.61	107.58	107.58	107.55
Less : Accumulated Depreciation	101.16	96.21	86.28	76.38	66.48	56.58
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	6.45	11.40	21.33	31.20	41.10	50.97
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1.87	1.87	1.87	1.87	1.87	1.87
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.11	0.11	0.01	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.03	0.09	0.02	0.04	0.03	0.04
Sundry Debtors	0.00	0.00	0.00	0.00	0.00	0.00
Cash and Bank	0.00	0.02	0.01	0.04	0.10	0.10
Loans and Advances	0.85	0.58	0.60	0.60	0.51	0.64
Total Current Assets	0.89	0.69	0.64	0.67	0.64	0.78
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.37	0.44	0.34	0.55	0.41	0.72
Provisions	1.82	1.41	6.93	6.99	6.99	6.99
Total Current Liabilities	2.19	1.85	7.28	7.54	7.39	7.71
Net Current Assets	-1.31	-1.16	-6.64	-6.87	-6.75	-6.93
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	7.12	12.21	16.56	26.20	36.22	45.91
Contingent Liabilities	0.99	0.99	0.99	0.99	0.99	0.99

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	75.77	75.77	75.77	75.77	75.77	75.77
Reserves Total	-64.40	-58.39	-53.53	-43.10	-32.13	-23.34
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	11.37	17.38	22.24	32.67	43.64	52.43
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	4.80	4.62	4.39	4.13	3.95	3.69
Unsecured Loans	8.31	7.39	6.94	6.20	5.19	6.15
Total Debt	13.11	12.01	11.33	10.33	9.14	9.84
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	115.57	115.75	115.92	116.10	116.27	116.45
Total Liabilities	140.05	145.14	149.49	159.10	169.05	178.72
APPLICATION OF FUNDS :
Gross Block	107.61	107.61	107.61	107.58	107.58	107.55
Less: Accumulated Depreciation	101.16	96.21	86.28	76.38	66.48	56.58
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	6.45	11.40	21.33	31.20	41.10	50.97
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1.87	1.87	1.87	1.87	1.87	1.87
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.10	0.10	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	0.03	0.09	0.02	0.04	0.03	0.04
Sundry Debtors	0.01	0.01	0.01	0.01	0.01	0.01
Cash and Bank	0.00	0.02	0.02	0.04	0.10	0.10
Loans and Advances	0.85	0.58	0.60	0.60	0.51	0.64
Total Current Assets	0.89	0.70	0.65	0.68	0.65	0.79
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	0.48	0.55	0.46	0.66	0.52	0.83
Provisions	1.82	1.41	6.93	6.99	6.99	6.99
Total Current Liabilities	2.30	1.97	7.39	7.65	7.51	7.82
Net Current Assets	-1.41	-1.27	-6.74	-6.97	-6.86	-7.03
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	133.05	133.04	133.04	133.00	132.93	132.92
Total Assets
Contingent Liabilities	0.99	0.99	0.99	0.99	0.99	0.99

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.02	0.01	0.04	0.10	0.10
Net Cash from Operating Activities	0.00	0.10	0.01	0.14	-1.74
Net Cash Used In Investing Activities	-0.01	-0.10	-0.04	0.00	1.74
Net Cash Used In Financing Activities	0.00	0.00	0.00	-0.20	0.00
Net Inc./Dec In Cash And Cash Equivalents	-0.01	0.00	-0.02	-0.06	0.00
Cash And Cash Equivalents At End Of The Year	0.00	0.02	0.01	0.04	0.10

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

21.68%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

70.04%

**Promoter pledged shareholding 21.68%

About Transgene Biotek Ltd

Transgene Biotek Ltd is in the Healthcare sector, having a market capitalization of Rs. 53.57 crores. It has reported a sales of Rs. 0.05 crores and a net profit of Rs. -0.12 crores for the quarter ended December 2018. The company management includes K Koteswara Rao, Sujana Kadiam,Ankita Jain,Santosh Kumar,K Koteswara Rao,Marri Swetha (Transgene Biotek Ltd) among others.

Chairman

K Koteswara Rao

Registered office

Plot No 69 & 70 IDA Bollaram,,Sangareddy,Telangana,502325

FAX :

Background

Incorporation Year1990

Face Value₹10

Market Lot1

How to buy Transgene Biotek shares on nse?

To buy Transgene Biotek shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Transgene Biotek share price today?

The Transgene Biotek shares price on nse is Rs.7.07 today.

What is the market cap of Transgene Biotek shares on BSE ?

The company has a market capitalization of Rs.53.57Cr

What is the PE & PB ratio of Transgene Biotek shares ?

PE is 0 and PB is -8.27

What is the 52 Week High and Low of Transgene Biotek shares?

Transgene Biotek stock price high: Rs.12.46 Transgene Biotek stock price low: Rs.2.82